Biosimilars – HCP supports healthcare professionals through independent education on biosimilar concepts, approval, and treatment options to strengthen their knowledge and confidence in biosimilar use.
HCP Education - Teva supports healthcare professionals, patients, and caregivers through independent education to strengthen clinical decisions and improve health behaviors or health status.
Schizophrenia – HCP supports educational providers delivering independent healthcare professional education on antipsychotics and long-acting injectables to improve treatment competence and prevent relapse.
Patient Education - Teva supports organizations that educate people with Huntington’s disease, tardive dyskinesia, or schizophrenia and their caregivers to improve understanding of symptoms, management, and treatment.
Huntington’s Disease - HCP supports healthcare professionals through independent medical education on diagnosis, treatment, and multidisciplinary care to strengthen Huntington’s disease management.
Accredited Independent Medical Education (CE/CME) Grant Funding supports third-party organizations delivering accredited education to close healthcare provider knowledge gaps and improve evidence-based care.